November 7, 2024 6:30 am EST Immunovant Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024
October 29, 2024 6:30 am EDT Immunovant Announces Oral Presentation of Late Breaking Abstract for Phase 2 Graves’ Disease Clinical Data at the 2024 American Thyroid Association (ATA) Annual Meeting